Monitor future equity grant activity under the new plan for potential dilution. The 2026 Plan's 3:1 share-counting ratio for full-value awards (RSUs) may accelerate share reserve consumption. No immediate trading catalyst.
Price Chart
Executive Summary
Ulta Beauty filed an 8-K reporting the results of its 2026 Annual Meeting, where stockholders approved a new 2026 Incentive Award Plan authorizing up to 5,001,201 shares, amendments to the certificate of incorporation for officer exculpation and exclusive forum provisions, and the election of all 10 director nominees. The filing is routine post-meeting administrative reporting with no material financial impact.
Key Facts
- Stockholders approved the 2026 Incentive Award Plan authorizing up to 5,001,201 shares of common stock (3,500,000 newly authorized + 1,501,201 rollover from prior plan).
- Stockholders approved amendments to the certificate of incorporation adding officer exculpation (per DGCL Section 102(b)(7)) and exclusive forum provisions for Delaware courts and federal courts for Securities Act claims.
- All 10 director nominees were elected with 94.21% to 99.72% of votes cast in favor.
- Ernst & Young LLP was ratified as independent auditor for fiscal 2026 with 88.08% of votes cast in favor.
- Advisory vote on executive compensation passed with 77.83% of votes cast in favor.
- The 2026 Plan replaces the prior 2011 Incentive Award Plan; no further grants will be made under the prior plan.
Financial Impact
No direct financial impact. The 2026 Plan authorizes up to 5,001,201 shares (~11.5% of outstanding shares as of record date) for future equity grants, but no immediate dilution or cash impact.
Risk Factors
- Potential future dilution from equity grants under the new 2026 Plan (up to ~11.5% of outstanding shares).
- Officer exculpation amendment may reduce board/management accountability risk for shareholders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-071896 |
| Document: ulta-20260609xex3d1.htm | 0001104659-26-071896 |
| Document: 0001104659-26-071896-index-headers.html | 0001104659-26-071896 |
| Document: 0001104659-26-071896-index.html | 0001104659-26-071896 |
| Document: 0001104659-26-071896.txt | 0001104659-26-071896 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | 8-K | $493.33 $544.32 | ▲ +10.34% | ▲ +12.31% | $543.69 (+10.21%) |
Jun 15, 2026 15w ago | 144 | $463.68 $469.12 | ▲ +1.17% | ▲ +0.97% | $543.69 (+17.26%) |
Jun 9, 2026 16w ago | 8-K | $470.75 $460.24 | ▼ −2.23% | ▼ −5.86% | $543.69 (+15.49%) |
Jun 2, 2026 17w ago | 8-K | $470.81 $454.78 | ▼ −3.40% | ▼ −2.28% | $543.69 (+15.48%) |
May 19, 2026 19w ago | Court Ruling | $481.56 $450.75 | ▼ −6.40% | ▼ −7.38% | $543.69 (+12.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access